OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.

PubMed

Year: 2002
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Renato Lenzi, Michael Rosenblum, Claire Verschraegen, Andrzej P Kudelka, John J Kavanagh, Marshall E Hicks, Eric A Lang, Michael A Nash, Lawrence B Levy, Michael E Garcia, Chris D Platsoucas, James L Abbruzzese, Ralph S Freedman
Institutions: Memorial Hermann, Memorial Hermann–Texas Medical Center, The University of Texas Health Science Center at Houston, Temple University
Language: English

Topic: Intraperitoneal and Appendiceal Malignancies
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: intraperitoneal administration, peritoneal carcinomatosis, Müllerian carcinoma, gastrointestinal cancer, peritoneal mesothelioma, dose-limiting toxicity, pharmacokinetics, pharmacodynamics, tumor immunology, tumor cell apoptosis, interferon-gamma, TNF-α, IL-10, peritoneal exudate cells, cytokine therapy
SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, National Center for Research Resources
Awards: General Clinical Research Center, LABORATORY STUDIES WITH INTRAPERITONEAL RHIL-12 THERAPY
OpenAlex ID: W2171923478
FWCI: 6.251
Cites: 35
Cited by: 103
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms